Abstract
Mast cells derive from a distinct precursor in the bone marrow [1] and migrate into most tissues, where they acquire distinct characteristics in response to different micro-environmental influences, such as stem cell factor, nerve growth factor, or the cytokines, interleukin (IL)-3, -4 and -6 [2]. Mast cells are responsible for allergic reactions but mounting evidence indicates that they also participate in inflammation [3, 4] and homeostasis [5]. They are present in the meninges [6–11], especially the dura mater, which contains a large proportion of the total intracranial histamine [12]. The mast cells in the dura resemble those in connective tissue since they stain metachromatically with toluidine blue [13] and immunohistochemically for rat mast-cell protease I [14]. Connective-tissue mast cells and mucosal mast cells vary considerably in their staining characteristics as well as in their cytokine content [2, 15]. The mast cells in the rat dura mater, staining violet with toluidine blue, are often seen next to blood vessels (Fig. 1A). This close association with blood vessels can be appreciated better with electron microscopy, showing mast cells “embracing” the endothelial cells that make up the blood vessel wall (Fig. 1B).
Keywords
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Rodewald H-R, Dessing M, Dvorak AM, Galli SJ (1996) Identification of a committed precursor for the mast cell lineage. Science 271: 818–822
Galli SJ (1993) New concepts about the mast cell. N Engl J Med 328: 257–265
Theoharides TC (1996) Mast cell: a neuroimmunoendocrine master player. Int J Tissue React 18: 1–21
McNeil HP, Gotis-Graham I (2000) Human mast cell subsets-distinct functions in inflammation. In Hamm Res 49: 3–7
Gurish MF, Austen KF (2001) The diverse roles of mast cells. J Exp Med 194: F1–F5
Dropp JJ (1979) Mast cells in the human brain. Acta Anat 105: 505–513
Edvinsson L, Cervos-Navarro J, Larsson LI et al (1977) Regional distribution of mast cells containing histamine, dopamine or 5-hydroxytryptamine in the mammalian brain. Neurology 27: 878–884
Edvinsson L, Owman C, Sjöberg NO (1976) Autonomic nerves, mast cells and amine receptors in human brain vessels. A histochemical and pharmacological study. Brain Res 115: 377–393
Pollard H, Bischoff S, Llorens-Cortes C, Schwartz JC (1976) Histidine decarboxylase and histamine in discrete nuclei of rat hypothalamus and the evidence for mast cells in the median eminence. Brain Res 118: 509–513
Ibrahim MZ (1974) The mast cells of the mammalian central nervous system. Part I. Morphology, distribution and histochemistry. J Neurol Sci 21: 431–478
Olsson Y (1968) Mast cells in the nervous system. Int Rev Cytol 24: 27–70
Orr EL, Pace KR (1984) The significance of dura mast cells as a source of histamine in the mouse brain. J Neurochem 42: 727–732
Pang X, Letourneau R, Rozniecki JJ et al (1996) Definitive characterization of rat hypothalamic mast cells. Neuroscience 73: 889–902
Dimitriadou V, Rouleau A, Tuong T et al (1996) Rat cerebral mast cells undergo phenotype changes during development. Dey Brain Res 97: 29–41
Bradding P, Okayama Y, Howarth PH et al (1995) Heterogeneity of human mast cells based on cytokine content. J Immunol 155: 297–307
Fricke B, Von During M, Andres KH (1997) Topography and immunocytochemical characterization of nerve fibers in the leptomeningeal compartments of the rat. A light-and electron-microscopical study. Cell Tissue Res 287: 11–22
Von During M, Fricke B, Dahlmann A (1995) Topography and distribution of nerve fibers in the posterior longitudinal ligament of the rat: an immunocytochemical and electron-microscopical study. Cell Tissue Res 281: 325–338
Von During M, Andres KH (1991) Sensory nerve fiber terminals in the arachnoid granulations of non-human primates. Neurosci Lett 127: 121–124
Von During M, Bauersachs M, Bohmer B et al (1990) Neuropeptide Y- and substance P like immunoreactive nerve fibers in the rat dura mater encephali. Anat Embryol (Berl) 182: 363–373
Keller JT, Marfurt CF (1991) Peptidergic and serotoninergic innervation of the rat dura mater. J Comp Neurol 309: S15–534
Dimitriadou V, Buzzi MG, Moskowitz MA, Theoharides TC (1991) Trigeminal sensory fiber stimulation induces morphologic changes reflecting secretion in rat dura mast cells. Neuroscience 44: 97–112
Dimitriadou V, Rouleau A, Trung Tuong MD et al (1997) Functional relationships between sensory nerve fibers and mast cells of dura mater in normal and inflammatory conditions. Neuroscience 77: 829–839
Lambracht-Hall M, Dimitriadou V, Theoharides TC (1990) Migration of mast cells in the developing rat brain. Dey Brain Res 56: 151–159
Dimitriadou V, Aubineau P, Taxi J, Seylaz J (1987) Ultrastructural evidence for a functional unit between nerve fibers and type II cerebral mast cells in the cerebral vascular wall. Neuroscience 22: 621–630
Newson B, Dahlström A, Enerbäck L, Ahlman H (1983) Suggestive evidence for a direct innervation of mucosal mast cells. Neuroscience 10: 565–570
Naukkarinen A, Harvima I, Paukkonen K et al (1993) Immunohistochemical analysis of sensory nerves and neuropeptides and their contacts with mast cells in developing and mature psoriatic lesions. Arch Dermatol Res 285: 341–346
Bienenstock J, Tomioka M, Matsuda H et al (1987) The role of mast cells in inflammatory processes: evidence for nerve mast cell interactions. Int Arch Allergy Appl Immunol 82: 238–243
Stead RH, Tomioka M, Quinonez G et al (1987) Intestinal mucosal mast cells in normal and nematode-infected rat intestines are in intimate contact with peptidergic nerves. Proc Natl Acad Sci USA 84: 2975–2979
Letourneau R, Pang X, Sant GR, Theoharides TC (1996) Intragranular activation of bladder mast cells and their association with nerve processes in interstitial cystitis. Br J Urol 77: 41–54
Skofitsch G, Savitt JM, Jacobowitz DM (1985) Suggestive evidence for a functional unit between mast cells and substance P fibers in the rat diaphragm and mesentery. Histochemistry 82: 5–8
Stead RH, Dixon MF, Bramwell NH et al (1989) Mast cells are closely apposed to nerves in the human gastrointestinal mucosa. Gastroenterology 97: 575–585
Aurora SK, Welch KM (2000) Migraine: imaging the aura. Curr Opin Neurol 13: 273–276
Markowitz S, Saito K, Moskowitz MA (1987) Neurogenically mediated leakage of plasma protein occurs from blood vessels in dura mater but not brain. J Neurosci 7: 4129–4136
Moskowitz MA (1993) Neurogenic inflammation in the pathophysiology and treatment of migraine. Neurology 43: S16–S20
Strassman AM, Raymond SA, Burstein R (1996) Sensitization of meningeal sensory neurons and the origin of headaches. Nature 384: 560–564
LaMerte FP, Merchant JA, Casale TB (1988) Acute systemic reactions to carbonless copy paper associate with histamine release. J Am Med Assoc 260: 242–243
Lutz E, Chan W, Track NS et al (1978) Release of vasoactive intestinal polypeptide in mast cells by histamine liberators. Nature 275: 661–662
Mannaioni PF, Masini E, Pistelli A et al (1991) Mast cells as a source of superoxide anions and nitric oxide-like factor: relevance to histamine release. Int J Tissue React 13: 271–278
Klein LM, Lavker RM, Matis WL, Murphy GF (1989) Degranulation of human mast cells induces an endothelial antigen central to leukocyte adhesion. Proc Natl Acad Sci USA 86: 8972–8976
Suzuki H, Miura S, Liu YY et al (1995) Substance P induces degranulation of mast cells and leukocyte adhesion to venular endothelium. Peptides 16: 1447–1452
Theoharides TC (1983) Mast cells and migraines. Perspect Biol Med 26: 672–675
Kudrow L, Kudrow DB, Sandweiss JH (1995) Rapid and sustained relief of migraine attacks with intranasal lidocaine: preliminary findings. Headache 35: 79–82
Olesen J, Friberg L, Olesen TS et al (1990) Timing and topography of cerebral blood flow, aura and headache during migraine attacks. Ann Neurol 28: 791–798
Olesen J, Thomsen LL, Iversen H (1994) Nitric oxide is a key molecule in migraine and other vascular headaches. Trends Pharmacol Sci 15: 149–153
Dimitriadou V, Lambracht-Hall M, Theoharides TC (1990) Can inhibition of carbachol or substance P induced selective release from mast cells be associated with analgesia (abstract). Pain 5 (Suppl): 514
Ottosson A, Edvinsson L (1997) Release of histamine from durai mast cells by substance P and calcitonin gene-related peptide. Cephalalgia 17: 166–174
Keller JT, Dimlich RV, Zuccarello M et al (1991) Influence of the sympathetic nervous system as well as trigeminal sensory fibers on rat durai mast cells. Cephalalgia 11: 215–221
Delepine L, Aubineau P (1997) Plasma protein extravasation induced in the rat dura mater by stimulation of the parasympathetic sphenopalatine ganglion. Exp Neurol 147: 389–400
Dimitriadou V, Buzzi MG, Theoharides TC, Moskowitz MA (1992) Ultrastructural evidence for neurogenically mediated changes in blood vessels of the rat dura mater and tongue following antidromic trigeminal stimulation. Neuroscience 48: 187–203
Williams RM, Bienenstock J, Stead RH (1995) Mast cells: the neuroimmune connection. Chem Immunol 61: 208–235
Foreman JC (1987) Neuropeptides and the pathogenesis of allergy. Allergy 42: 1–11
Theoharides TC (1990) Mast cells: the immune gate to the brain. Life Sci 46: 607–617
Marshall JS, Waserman S (1995) Mast cells and the nerves — potential interactions in the context of chronic disease. Clin Exp Allergy 25: 102–110
Silver R, Silverman A-J, Vitkovic L, Lederhendler II (1996) Mast cells in the brain: evidence and functional significance. Trends Neurosci 19: 25–31
Kines KC, Powell HC (1997) Mast cell interactions with the nervous system: relationship to mechanisms of disease. J Neuropathol Exp Neurol 56: 627–640
Purcell WM, Westgate C, Atterwill CK (1996) Rat brain mast cells: an in vitro paradigm for assessing the toxic effects of neurotropic therapeutics. Neuro Toxicol 17: 845–850
Rasmussen BK (1993) Migraine and tension-type headache in a general population: precipitating factors, female hormones, sleep pattern and relation to life style. Pain 53: 65–72
Chrousos GP (1995) The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation. N Engl J Med 332: 1351–1362
Theoharides TC, Spanos CP, Pang X et al (1995) Stress-induced intracranial mast cell degranulation. A corticotropin releasing hormone-mediated effect. Endocrinology 136: 5745–5750
Rozniecki JJ, Dimitriadou V, Lambracht-Hall M et al (1999) Morphological and functional demonstration of rat dura mast cell-neuron interactions in vitro and in vivo. Brain Res 849: 1–15
Theoharides TC, Singh L, Boucher W et al (1998) Corticotropin-releasing hormone induces skin mast cell degranulation and increased vascular permeability, a possible explanation for its pro-inflammatory effects. Endocrinology 139: 403–413
Rivest S, Laflamme N, Nappi RE (1995) Immune challenge and immobilization stress induce transcription of the gene encoding the CRF receptor in selective nuclei of the rat hypothalamus. J Neurosci 15: 2680–2695
Esposito P, Gheorghe D, Kandere K et al (2001) Acute stress increases permeability of the blood-brain-barrier through activation of brain mast cells. Brain Res 888: 117–127
Kandere K, Dimitriadou V, Gheorge D et al (2001) Acute stress increases vascular extravasation of 99techetium-gluceptate in the dura mater but not in mast cell deficient, neurokinin-1 or substance P knock-out mice. J Clin Invest; in press
Diamond S (1991) Migraine headaches. Med Clin North Am 75: 545–566
Van der Werf JF, Timmerman H (1989) The histamine H3 receptor: a general presynaptic histaminergic regulatory system? TIPS 10: 159–162
Leurs R, Blandina P, Tedford C, Timmerman H (1998) Therapeutic potential of histamine H3 receptor agonists and antagonists. TIPS 19: 177–183
Rozniecki JJ, Letourneau R, Sugiultzoglu M et al (1999) Differential effect of histamine-3 receptor active agents on brain but not peritoneal mast cell activation. J Pharmacol Exp Ther 290: 1–9
Matsubara T, Moskowitz MA, Huang Z (1992) UK-14,304 R(—)-a-methyl-histamine and SMS 201–995 block plasma protein leakage within dura mater by prejunctional mechanisms. Eur J Pharmacol 224: 145–150
Dimitriadou V, Rouleau A, Dam Trung Tuong M et al (1994) Functional relationship between mast cells and C-sensitive nerve fibers evidenced by histamine H3-receptor modulation in rat lung and spleen. Clin Sci 87: 151–163
Rouleau A, Stark H, Schunack W, Schwartz J-C (2000) Anti-inflammatory and antinoci-ceptive properties of BP 2–94, a histamine H3-receptor agonist prodrug. J Pharmacol Exp Ther 295: 219–225
Edvinsson L (1995) Experimental headache models in animals and humans. TIPS 16: 5–9
Moskowitz MA (1992) Neurogenic versus vascular mechanisms of sumatriptan and ergot alkaloids in migraine. TIPS 13: 307–311
Bergerot A, Reynier-Rebuffel AM, Callebert J, Aubineau P (2000) Long-term superior cervical sympathectomy induces mast cell hyperplasia and increases histamine and serotonin content in the rat dura mater. Neuroscience 96: 205–213
Buzzi MG, Dimitriadou V, Theoharides TC, Moskowitz MA (1992) 5-Hydroxytryptamine receptor agonists for the abortive treatment of vascular headaches block mast cell, endothelial and platelet activation within the rat dura mater after trigeminal stimulation. Brain Res 583: 137–149
Liberski PP, Prusinski A (1982) Further observations on the mast cells over the painful region in cluster headache patients. Headache 22: 115–117
Liberski PP, Mirecka B (1984) Mast cells in cluster headache: ultrastructure, release pattern and possible pathogenetic significance. Cephalalgia 4: 101–106
Dimitriadou V, Henry P, Brochet B et al (1990) Cluster headache: ultrastructural evidence for mast cell degranulation and interaction with nerve fibers in the human temporal artery. Cephalalgia 10: 221–228
Russell AL, McCarty MF (2000) Glucosamine for migraine prophylaxis. Med Hypotheses 55: 195–198
Anthony M, Lance JW (1971) Histamine and serotonin in cluster headache. Arch Neu-rol 25: 225–231
Heatley RV, Denburg JA, Bayer N, Bienenstock J (1982) Increased plasma histamine levels in migraine patients. Clin Allergy 12: 145–149
Krabbe AA, Olesen J (1980) Headache provocation by continuous intravenous infusion of histamine, clinical results and receptor mechanisms. Pain 8: 253–259
Olness K, Hall H, Rozniecki JJ et al (1999) Mast cell activation in children with migraine before and after training in self-regulation. Headache 39: 101–107
Foreman JC (1987) Peptides and neurogenic inflammation. Brain Res Bull 43: 386–398
Ali H, Leung KBP, Pearce FL et al (1986) Comparison of the histamine-releasing action of substance P on mast cells and basophils from different species and tissues. Int Arch Allergy Appl Immunol 79: 413–418
Fewtrell CMS, Foreman JC, Jordan CC et al (1982) The effects of substance P on histamine and 5-hydroxytryptamine release in the rat. J Physiol 330: 393–411
Hakanson R, Leander S, Andersson RG, Honig J (1983) Substance P antagonists release histamine from peritoneal mast cells. Acta Physiol Scand 117: 319–320
Shanahan F, Denburg JA, Fox J et al (1985) Mast cell heterogeneity: effects of neuroenteric peptides on histamine release. J Immunol 135: 1331–1337
Lowman MA, Rees PH, Benyon RC, Church MK (1988) Human mast cell heterogeneity: histamine release from mast cells dispersed from skin, lung, adenoids, tonsils, and colon in response to IgE-dependent and nonimmunologic stimuli. J Allergy Clin Immunol 81: 590–597
Janiszewski J, Bienenstock J, Blennerhassett MG (1994) Picomolar doses of substance P trigger electrical responses in mast cells without degranulation. Am J Physiol 267: C138–C145
Matsuda H, Kawakita K, Kiso Y et al (1989) Substance P induces granulocyte infiltration through degranulation of mast cells. J Immunol 142: 927–931
Glover V, Sandler M (1989) Can the vascular and neurogenic theories of migraine be reconciled? TIPS 10: 1–3
Walsh LJ, Trinchieri G, Waldorf HA et al (1991) Human dermal mast cells contain and release tumor necrosis factor a, which induces endothelial leukocyte adhesion molecule 1. Proc Natl Acad Sci USA 88: 4220–4224
Goadsby PJ, Edvinsson L, Ekman R (1990) Vasoactive peptide release in the extracerebral circulation of humans during migraine headache. Ann Neurol 28: 183–187
Stepien A (1999) The role of nitrogen oxide in migraine attack. Neurol Neurochir Pol 33: 435–444
Brooks AC, Whelan CJ, Purcell WM (1999) Reactive oxygen species generation and histamine release by activated mast cells: modulation by nitric oxide synthase inhibition. Br J Pharmacol 128: 585–590
Gaboury JP, Niu X-F, Kubes P (1996) Nitric oxide inhibits numerous features of mast cell-induced inflammation. Circulation 93: 318–326
Kubes P, Kanwar S, Niu X-F, Gaboury JP (1993) Nitric oxide synthesis inhibition induces leukocyte adhesion via superoxide and mast cells. FASEB J 7: 1293–1299
Sternberg EM, Chrousos GP, Wilder RL, Gold PW (1992) The stress response and the regulation of inflammatory disease. Ann Intern Med 117: 854–866
Chalmers DT, Lovenberg TW, Grigoriadis DE et al (1996) Corticotropin-releasing factor receptors: from molecular biology to drug design. TIPS 17: 166–172
Spiess J, Dautzenberg FM, Sydow Set al (1998) Molecular properties of the CRF receptor. Trends Endocrinol Metab 9: 140–145
Kubler A, Rothacher G, Knappertz VA et al (1994) Intra and extracerebral blood flow changes and flushing after intravenous injection of human corticotropin-releasing hormone. Clin Invest 72: 331–336
Udelsman R, Harwood JP, Millan MA et al (1986) Functional corticotropin-releasing factor receptors in the primate peripheral nervous system. Nature 319: 146–150
Karalis K, Sano H, Redwine J et al (1991) Autocrine or paracrine inflammatory actions of corticotropin-releasing hormone in vivo. Science 254: 421–423
Merchenthaler I, Hynes MA, Vingh S et al (1983) Immunocytochemical localization of corticotropin-releasing factor (CRF) in the rat spinal cord. Brain Res 275: 373–377
Skofitsch G, Zamir N, Helke CJ et al (1985) Corticotropin-releasing factor-like immunoreactivity in sensory ganglia and capsaicin sensitive neurons of the rat central nervous system: colocalization with other neuropeptides. Peptides 6: 307–318
Suda T, Tomori N, Tozawa F et al (1984) Distribution and characterization of immuno-reactive corticotropin-releasing factor in human tissues. J Clin Endocrinol Metab 59: 861–866
Udelsman R, Gallucci WT, Bacher J et al (1986) Hemodynamic effects of corticotropin-releasing hormone in the anesthetized cynomolgus monkey. Peptides 7: 465–467
Chalmers DT, Lovenberg TW, DeSouza EB (1995) Localization of novel corticotropin-releasing factor receptor (CRF2) mRNA expression to specific subcortical nuclei in rat brain: comparison with CRF1 receptor mRNA expression. J Neurosci 10: 6340–6350
Clifton VL, Read MA, Leitch IM et al (1995) Corticotropin-releasing hormone-induced vasodilatation in the human fetal-placental circulation: involvement of the nitric oxide-cyclic guanosine 3’,5’-monophosphate-mediated pathway. J Clin Endocrinol Metab 80: 2888–2893
Singh LK, Pang X, Alexacos N et al (1999) Acute immobilization stress triggers skin mast cell degranulation via corticotropin-releasing hormone, neurotensin and substance P: A link to neurogenic skin disorders. Brain Behavior Immunity 13: 225–239
Karalis K, Louis JM, Bae D et al (1997) CRH and the immune system. J Neuroimmunol 72: 131–136
Singh LK, Boucher W, Pang X et al (1999) Potent mast cell degranulation and vascular permeability triggered by urocortin through activation of CRH receptors. J Pharm Exp Ther 288: 1349–1356
Horan RF, Austen KF (1991) Systemic mastocytosis: retrospective review of a decade’s clinical experience at the Brigham and Women’s Hospital. J Invest Dermatol 96: 55–145
Longley J, Duffy TP, Kohn S (1995) The mast cell and mast cell disease. J Am Acad Dermatol 32: 545–561
Buzzi MG, Moskowitz MA (1990) The antimigraine drug, sumatriptan (GR43175), selectively blocks neurogenic plasma extravasation from blood vessels in dura mater. Br J Pharmacol 99: 202–206
Buzzi MG, Moskowitz MA (1991) Evidence for 5-HT1B/1D receptors mediating the antimigraine effect of sumatriptan and dihydroergotamine. Cephalalgia 11: 165–168
Williamson DJ, Shepheard SL, Hill RG, Hargreaves RJ (1997) The novel anti-migraine agent rizatriptan inhibits neurogenic durai vasodilation and extravasation. Eur J Pharmacol 328: 61–64
Deleu D, Hanssens Y (2000) Current and emerging second-generation triptans in acute migraine therapy:a comparative review. J Clin Pharmacol 40: 687–700
Bartleson JD (1999) Treatment of migraine headaches. Mayo Clin Proc 74: 702–708
Deleu D, Hanssens Y, Worthing EA (1998) Symptomatic and prophylactic treatment of migraine:a critical reappraisal. Clin Neuropharmacol 21: 267–279
De Felipe C, Herrero JF, O’Brien JA et al (1998) Altered nociception, analgesia and aggression in mice lacking the receptor for substance P. Nature 392: 394–397
Bozic CR, Lu B, Höpken UE et al (1996) Neurogenic amplification of immune complex inflammation. Science 273: 1722–1725
Hill R (2000) NKl (substance P) receptor antagonists — why are they not analgesic in humans? TIPS 21: 244–246
Goldstein DJ, Wang O, Saper JR et al (1997) Ineffectiveness of neurokinin-1 antagonist in acute migraine: a crossover study. Cephalalgia 17: 785–790
Roon KI, Olesen J, Diener HC et al (2000) No acute antimigraine efficacy of CP-122,288, a highly potent inhibitor of neurogenic inflammation: results of two randomized, double-blind, placebo-controlled clinical trials. Ann Neurol 47: 238–241
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2002 Springer Basel AG
About this chapter
Cite this chapter
Theoharides, T.C., Kandere, K. (2002). Mast cell involvement in neurogenic inflammation. In: Spierings, E.L.H., Sánchez del Río, M. (eds) Migraine: A Neuroinflammatory Disease?. Progress in Inflammation Research. Birkhäuser, Basel. https://doi.org/10.1007/978-3-0348-8131-9_7
Download citation
DOI: https://doi.org/10.1007/978-3-0348-8131-9_7
Publisher Name: Birkhäuser, Basel
Print ISBN: 978-3-0348-9449-4
Online ISBN: 978-3-0348-8131-9
eBook Packages: Springer Book Archive